Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Betamethasone Dipropionate on Patients With Eosinophilic Chronic Rhinosinusitis

NCT05220293 is registered in ClinicalTrials.gov with Oticara Australia PTY LTD as lead sponsor.

NCT NCT05220293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05220293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Betamethasone Dipropionate on Patients With Eosinophilic Chronic Rhinosinusitis
Lead sponsor
Oticara Australia PTY LTD
Phase
Phase 1/2
Overall status
Terminated
Start date
February 23, 2022
Completion date
December 30, 2023
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis (diagnosis)